Episode 128: Enabling Pharmaceutical Innovation with Mike Rea from IDEA Pharma
March 16, 201729:11

Episode 128: Enabling Pharmaceutical Innovation with Mike Rea from IDEA Pharma

Mike Rea has worked in global pharma strategy for over 25 years, working with the world’s top 30 pharmaceutical companies. Regarded as an industry thought leader in innovation, Mike helped lead the strategic direction of over 100 pharmaceutical brands, and created the industry standard annual Productive Innovation Index, a ranking of top 30 pharma by their ability to launch innovation.

Mike’s passion for industry change has inspired those around him, and IDEA Pharma’s clients, to think differently, to challenge the status quo and achieve strategic excellence. Under Mike’s guidance, IDEA has supported over 3 in 4 of ‘blockbuster contenders’ in industry pipelines (cited by FiercePharma), positioned the top 2 launches of 2015, and over half of the 50 fastest growing drugs in the 2010-15 window.

Individually, Mike has been:

  • Named as one of the 100 Most Inspiring People in Healthcare in 2011, 2013 and 2015, and was presented the Red Jacket Lifetime Achievement award in 2016 (PharmaVoice)

  • Voted one of Top 10 Innovators in Pharma (PharmaPhorum)

  • Acknowledged as the industry’s leading expert in early-phase Positioning, and has successfully positioned some of the world’s leading pharmaceutical products

  • Is leading the development of an industry Code of Ethics

Outside work, Mike owns an independent record label (Medical Records), organises the street food/ food truck festival MXMK, and cycles really slowly…


00:00 Using ‘Innovation’ incorrectly.
01:45 Why the textbook definition of Innovation matters within Healthcare.
02:30 “No Medicine is less useful than one that doesn’t make it to Patients.”
03:00 True Pharma Innovations that Mike is most excited about.
04:35 Mike explains what Med-Tech Devices are.
07:00 How EEGs are improving Healthcare.
08:30 Explaining ‘Electroceuticals’.
09:20 Explaining ‘Interventional AI’.
12:00 Finding funding and looking at profit realistically within Pharma Innovation.
16:20 “Creating Value based on other means.”
18:00 “There are so many different ways we could begin to think of different business relationships with our customers.”
21:45 How Payers fit into Care Pathways.
24:00 Why Pharma should be thinking about Innovation.
29:00 “For every assest is there a faster way to do this? Is there a bigger way to do this?”
31:00 You can find out more information at ideapharma.com or @ideapharma on twitter.

healthcare,health,pharma,marketing,innovation,idea pharma,pharmaceutical innovation,
|
|

Episode Support Provided By

Special Thanks to Our 2026 Sustaining Monthly Donors

Marilyn Bartlett, Kimberly Carleson, Dylan Yahn, Benjamin Light, Matt McQuideAnn Kempski, Spencer Allen, Scott Tromanhauser, 
Steven Elkins, Matthew Bunte, and Lori Smith.

Recent Episodes

EP525: PMPM vs FFS—The Perverse Incentives Plan Sponsors Sometimes Miss, With Cristin Dickerson, MD
Relentless Health ValueAugust 19, 2026
525
16:3315.14 MB

EP525: PMPM vs FFS—The Perverse Incentives Plan Sponsors Sometimes Miss, With Cristin Dickerson, MD

Listen on Your Favorite App So, this one's gonna be a little bit different. Back last year, I sat down with Dr. Cristin Dickerson. She is the founding partner of Green Imaging , which is a physician-led radiology network doing direct contracting for imaging. And we talked about how imaging can run 6...

EP524: Beating Provider Network Pricing Games by Thinking About Buying Healthcare Like a Manufacturer Supply Chain, With John Quinn
Relentless Health ValueAugust 12, 2026
524
17:0215.59 MB

EP524: Beating Provider Network Pricing Games by Thinking About Buying Healthcare Like a Manufacturer Supply Chain, With John Quinn

Listen on Your Favorite App Hello, all you Relentless Tribe members. First off here, I would like to thank Casey Cormier for the really nice recurring donation. Thank you so much, Casey Cormier from  Stratis Group . Lately, traditional provider networks are increasingly being called into questi...

EP523: The Sleeping Giants of Healthcare—Why Self-insured Employers and Clinicians Keep Missing Each Other, With Suhas Gondi, MD, MBA
Relentless Health ValueAugust 05, 2026
523
35:1632.28 MB

EP523: The Sleeping Giants of Healthcare—Why Self-insured Employers and Clinicians Keep Missing Each Other, With Suhas Gondi, MD, MBA

Listen on Your Favorite App Hello, all you Relentless Tribe members. Before we dive in today, I just wanted to give a quick but massive thank you to Alex Sommers, MD, ABEM, DipABLM, from Astia Health for his generous gift, which we are going to use to help fund a camera for the podcast here to level...

EP522: How Exactly Does GoodRx Make Money? With Ge Bai, PhD, CPA
Relentless Health ValueJuly 29, 2026
522
13:4512.58 MB

EP522: How Exactly Does GoodRx Make Money? With Ge Bai, PhD, CPA

Listen on Your Favorite App Arielle Bose: Hi, Stacey. This is Arielle Bose from EHD Insurance . Big fan of the podcast. We were talking about GoodRx the other day, and it occurred to me that I’m not exactly clear about how they make money. So, Stacey, how does GoodRx make money? For a full transcrip...

EP521: How Revenue Cycle Management (RCM) Became an Over $200 Billion Healthcare Hot Potato, With Andrew Tsang
Relentless Health ValueJuly 22, 2026
521
36:1333.15 MB

EP521: How Revenue Cycle Management (RCM) Became an Over $200 Billion Healthcare Hot Potato, With Andrew Tsang

Listen on Your Favorite App Hey, welcome to Relentless Health Value. Okay … so, on today's show, we are talking about (Andrew Tsang and I) revenue cycle management, which—I say this with real affection—is maybe the least sexy phrase in all of healthcare. It sounds like a back-office spreadsheet prob...

EP520: Cash-Pay Generic Drugs Are a Functioning Market in Healthcare—Policymakers Beware and Be Careful
Relentless Health ValueJuly 15, 2026
520
32:1829.56 MB

EP520: Cash-Pay Generic Drugs Are a Functioning Market in Healthcare—Policymakers Beware and Be Careful

Listen on Your Favorite App In the pachinko machine that is the healthcare industry, with just so many intermediaries, with so much regulatory capture and conflicts of interest that may or may not be visible, so much margin that is shrouded in mystery in an ecosystem as messy as this with so many va...

EP519: The Current State of Primary Care—Inevitable or Fixable? With Lisa Rosenbaum, MD
Relentless Health ValueJuly 08, 2026
519
40:0036.61 MB

EP519: The Current State of Primary Care—Inevitable or Fixable? With Lisa Rosenbaum, MD

Listen on Your Favorite App Hello, all you Relentless Tribe members. Today, let's start here. Right now, we are watching a very visible exodus of brilliant, consummate primary care (and other, honestly) physicians leaving traditional practice for concierge medicine or otherwise. For a full transcrip...

Listen and Follow

Sponsored by Aventria Health Group
©2026 BD Bridges LLC. All Rights Reserved.